UK markets close in 3 hours 14 minutes

CytomX Therapeutics, Inc. (CTMX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.6500+0.1500 (+10.00%)
At close: 04:00PM EST
1.6496 -0.00 (-0.02%)
Pre-market: 08:00AM EST
Currency in USD
Earnings estimateCurrent qtr. (Dec 2023)Next qtr. (Mar 2024)Current year (2023)Next year (2024)
No. of analysts7476
Avg. Estimate-0.030-0.05-0.19
Low estimate-0.24-0.1-0.28-0.72
High estimate0.120.110.110.2
Year ago EPS-0.43-0.05-1.51-0.05
Revenue estimateCurrent qtr. (Dec 2023)Next qtr. (Mar 2024)Current year (2023)Next year (2024)
No. of analysts7575
Avg. Estimate21.04M20.92M95.62M78.34M
Low estimate10M12.5M85M50M
High estimate31.1M31.1M105.71M104M
Year ago sales946k23.5M53.16M95.62M
Sales growth (year/est)2,124.10%-11.00%79.90%-18.10%
Earnings history30/12/202230/03/202329/06/202329/09/2023
Est. EPS-0.24-0.11-0.2-0.19
Actual EPS-0.43-0.05-0.020.04
Difference-0.190.060.180.23
Surprise %-79.20%54.50%90.00%121.10%
EPS trendCurrent qtr. (Dec 2023)Next qtr. (Mar 2024)Current year (2023)Next year (2024)
Current estimate-0.030-0.05-0.19
7 days ago-0.030-0.05-0.19
30 days ago-0.04-0.03-0.06-0.23
60 days ago-0.040.03-0.06-0.37
90 days ago-0.050.02-0.07-0.43
EPS revisionsCurrent qtr. (Dec 2023)Next qtr. (Mar 2024)Current year (2023)Next year (2024)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesCTMXIndustrySector(s)S&P 500
Current qtr.93.00%N/AN/AN/A
Next qtr.100.00%N/AN/AN/A
Current year96.70%N/AN/AN/A
Next year-280.00%N/AN/AN/A
Next 5 years (per annum)-0.90%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A